Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
4.340
-0.150 (-3.34%)
At close: Mar 20, 2026
-9.77% (1Y)
| Market Cap | 3.05B -13.2% |
| Revenue (ttm) | 430.61M +55.3% |
| Net Income | -118.38M |
| EPS | -0.16 |
| Shares Out | 703.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,946,974 |
| Average Volume | 8,227,202 |
| Open | 4.480 |
| Previous Close | 4.490 |
| Day's Range | 4.330 - 4.550 |
| 52-Week Range | 3.450 - 7.050 |
| Beta | 0.37 |
| RSI | 44.47 |
| Earnings Date | Apr 25, 2026 |